Cite
APA Citation
Crabtree, T. S. J., Adamson, K., Reid, H., Barnes, D., Sivappriyan, S., Bickerton, A., Gallen, I. W., Field, B. C. T., Idris, I., Ryder, R. E. J., & , (2022). injectable semaglutide and reductions in HbA1c and weight in the real world in people switched from alternative glucagon‐like peptide‐1 receptor agonists. Diabetes, obesity & metabolism, 24(7), 1398–1401. http://access.bl.uk/ark:/81055/vdc_100156460819.0x000021